Home
Latest
E-paper
Companies
Industry
Economy
Finance
Markets
Budget 2025
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Video Gallery
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Don’t miss the latest developments in business and finance.
After Patanjali, state government, IMA comes under Supreme Court's scanner
The Supreme Court had earlier said that IMA needs to 'put its house in order'
Ichnos Sciences, Astria Therapeutics sign licensing deal for OX40 portfolio
Ichnos is set to receive $320 million upfront for development, regulatory and sales payments, coupled with low double-digit royalties
New National Medical Commission tag no game changer for medical students
Had the recognition not come, then students from several colleges may have found it difficult to appear for the USMLE if their college was not recognised by the WFME
Health ministry plans drug licensing changes to ensure drug safety
Proposals aim to standardise drug manufacturing practices after a few Indian medicines were flagged as 'substandard' by the WHO
FDA authorises third antibody drug for mild-to-moderate Covid-19 cases
U.S. health officials have granted emergency authorisation to a third antibody drug to help reduce hospitalisations and deaths due to Covid-19
Biocon and Equillium Inc. expand license agreement for itolizumab
The companies have expanded their collaboration and license agreement
Pharma industry divided as govt likely to increase drug licensing fee
Price hike likely to arrest the number of bogus drug registrations
Panel suggests one-time licensing for drugs
At present, the renewal of licences for each formulation rests with state regulators and is around 3 years